{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:27:12Z","timestamp":1764174432560,"version":"3.44.0"},"reference-count":25,"publisher":"BMJ","issue":"1","funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2017,12,20]]},"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>We evaluated whether early measurement of soluble urokinase plasminogen activator receptor (suPAR) could predict future risk of postoperative complications in initially asymptomatic patients with mild-moderate aortic stenosis (AS) undergoing aortic valve replacement (AVR) surgery.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Baseline plasma suPAR levels were available in 411 patients who underwent AVR surgery during follow-up in the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study. Cox analyses were used to evaluate suPAR in relation to all-cause mortality and the composite endpoint of postoperative complications (all-cause mortality, congestive heart failure, stroke and renal impairment) occurring in the 30-day postoperative period.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients with initially higher levels of suPAR were at increased risk of postoperative mortality with a HR of 3.5 (95% CI 1.4 to 9.0, P=0.008) and postoperative complications with a HR of 2.7 (95% CI 1.5 to 5.1, P=0.002), per doubling in suPAR. After adjusting for the European System for Cardiac Operative Risk Evaluation or Society of Thoracic Surgeons risk score, suPAR remained associated with postoperative mortality with a HR 3.2 (95%\u2009CI 1.2 to 8.6, P=0.025) and 2.7 (95% CI 1.0 to 7.8, P=0.061); and postoperative complications with a HR of 2.5 (95% CI 1.3 to 5.0, P=0.007) and 2.4 (95% CI 1.2 to 4.8, P=0.011), respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Higher baseline suPAR levels are associated with an increased risk for postoperative complications and mortality in patients with mild-moderate, asymptomatic AS undergoing later AVR surgery. Further validation in other subsets of AS individuals are warranted.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"NCT00092677\" ext-link-type=\"clintrialgov\">NCT00092677<\/jats:ext-link>; Post-results.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2017-000743","type":"journal-article","created":{"date-parts":[[2018,1,13]],"date-time":"2018-01-13T20:11:10Z","timestamp":1515874270000},"page":"e000743","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["SuPAR predicts postoperative complications and mortality in patients with asymptomatic aortic stenosis"],"prefix":"10.1136","volume":"5","clinical-trial-number":[{"clinical-trial-number":"nct00092677","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00092677","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Gethin W","family":"Hodges","sequence":"first","affiliation":[{"name":"Department of Medicine, Amager Hvidovre Hospital Glostrup, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casper N","family":"Bang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Zealand University Hospital, Roskilde, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper","family":"Eugen-Olsen","sequence":"additional","affiliation":[{"name":"Clinical Research Centre, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H","family":"Olsen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Holbaek Hospital, Holb\u00e6k, Denmark"},{"name":"Centre for Individualized Medicine in Arterial Diseases, Odense University Hospital, University of Southern Denmark, Odense, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Boman","sequence":"additional","affiliation":[{"name":"Research Unit, Skellefte\u00e5, Department of Public Health and Clinical Medicine, Ume\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Ray","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospitals of South Manchester, Manchester Academic Health Sciences Centre, Manchester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antero Y","family":"Kes\u00e4niemi","sequence":"additional","affiliation":[{"name":"Research Institute of Internal Medicine, Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen L","family":"Jeppesen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Amager Hvidovre Hospital Glostrup, University of Copenhagen, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian","family":"Wachtell","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Oslo University Hospital, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,1,13]]},"reference":[{"key":"2025081711135560000_5.1.e000743.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2015.03.023"},{"key":"2025081711135560000_5.1.e000743.2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nm.4362","article-title":"A tripartite complex of suPAR, APOL1 risk variants and \u03b1v\u03b23 integrin on podocytes mediates chronic kidney disease","volume":"23","author":"Hayek","year":"2017","journal-title":"Nat Med"},{"key":"2025081711135560000_5.1.e000743.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506362"},{"key":"2025081711135560000_5.1.e000743.4","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1478-3231.2011.02665.x","article-title":"Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis","volume":"32","author":"Zimmermann","year":"2012","journal-title":"Liver Int"},{"key":"2025081711135560000_5.1.e000743.5","first-page":"1462","article-title":"SuPAR predicts cardiovascular events and mortality in patients with asymptomatic aortic stenosis","volume":"32","author":"Hodges","year":"2016","journal-title":"Can J Cardiol"},{"key":"2025081711135560000_5.1.e000743.6","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3390\/ijms18081662","article-title":"Elevated soluble urokinase plasminogen activator receptor and proenkephalin serum levels predict the development of acute kidney injury after cardiac surgery","volume":"18","author":"Mossanen","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2025081711135560000_5.1.e000743.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2007.08.058"},{"key":"2025081711135560000_5.1.e000743.8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr061"},{"key":"2025081711135560000_5.1.e000743.9","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezs043"},{"key":"2025081711135560000_5.1.e000743.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2009.05.056"},{"key":"2025081711135560000_5.1.e000743.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2009.05.055"},{"key":"2025081711135560000_5.1.e000743.12","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1161\/CIRCULATIONAHA.108.808857","article-title":"Risk score for predicting outcome in patients with asymptomatic aortic stenosis","volume":"120","author":"Monin","year":"2009","journal-title":"Circulation"},{"key":"2025081711135560000_5.1.e000743.13","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2011-300475"},{"key":"2025081711135560000_5.1.e000743.14","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-307742"},{"key":"2025081711135560000_5.1.e000743.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.10.064"},{"key":"2025081711135560000_5.1.e000743.16","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.21114"},{"key":"2025081711135560000_5.1.e000743.17","unstructured":"Criteria Committee of the New York Heart Association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th edn. Boston, Massachusetts: Little, Brown & Co, 1994:253\u20136."},{"key":"2025081711135560000_5.1.e000743.18","doi-asserted-by":"crossref","first-page":"466","DOI":"10.12688\/f1000research.10510.1","article-title":"Unwinding focal segmental glomerulosclerosis","volume":"6","author":"Peev","year":"2017","journal-title":"F1000Res"},{"key":"2025081711135560000_5.1.e000743.19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrneph.2017.109","article-title":"SuPAR and FSGS: is the jury still out?","volume":"13","author":"Gallon","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"2025081711135560000_5.1.e000743.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60595-4"},{"key":"2025081711135560000_5.1.e000743.21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3365"},{"key":"2025081711135560000_5.1.e000743.22","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/504294"},{"key":"2025081711135560000_5.1.e000743.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2010.02252.x"},{"key":"2025081711135560000_5.1.e000743.24","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001118"},{"key":"2025081711135560000_5.1.e000743.25","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezu380"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2017-000743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T18:14:04Z","timestamp":1755454444000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2017-000743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,13]]},"published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1136\/openhrt-2017-000743"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2017-000743","relation":{},"ISSN":["2053-3624"],"issn-type":[{"type":"electronic","value":"2053-3624"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}